AI Addressing Global Health Challenges

By Sumona Bose

February 1, 2024

Introduction

In the era of the digital revolution, the expansion of artificial intelligence (AI) has emerged as a powerful tool to address global health challenges. With the rapid production and accessibility of health-related data, AI has the potential to change the field and mitigate the impact of various health issues. This article explores the relevance of AI in contemporary public health and its potential to strengthen global health through personalized healthcare and improved preparedness and response to future challenges. The core aspect this article unpacks is how is AI addressing global challenges.

AI Applications for Global Health Challenges

AI has the capability to understand complicated health and medical data, enabling it to perform various functions and deep-learning strategies. By harnessing its capabilities, AI can address leading global health challenges such as mental health, climate change, cardiovascular diseases, diabetes, infectious diseases, health systems, and population aging. Through computational models and algorithms, AI can provide insights and solutions to these challenges, ultimately improving health outcomes worldwide.

Strengthening Global Health through Personalized Healthcare

One of the key benefits of AI in healthcare is its ability to provide personalized healthcare. By analyzing vast amounts of data, AI can predict outcomes, mine data for valuable insights, and tailor treatment plans to individual patients. This holistic approach enhances primary healthcare systems, enabling better outcome prediction, data mining, and personalized treatment. AI can also improve health communication by analyzing online health information and providing personalized messaging to influence individuals’ health behaviors. This technology-driven approach amplifies the effectiveness of health interventions and improves patient-provider communication.

Figure 1: Examples of global health challenges.

Ethical and Legal Considerations

While AI holds immense potential in addressing global health challenges, ethical and legal concerns must be addressed for effective implementation. Privacy and autonomy of individuals and communities are paramount, and safeguards must be in place to protect them. The EU AI Act, the first comprehensive regulation addressing the risks of AI, aims to ensure better conditions for developing and using this innovative technology. Additionally, researchers are urged to provide more transparency and explainability in AI applications to avoid hindering its potential in healthcare. Explainable AI (xAI) is an approach that promotes human-interpretable AI-based applications, fostering trust and understanding.

Conclusion

Artificial intelligence has the power to inform global health by addressing various challenges and strengthening healthcare systems. Through personalized healthcare, improved communication, and better prediction and response to health issues, AI can significantly improve health outcomes worldwide. However, ethical and legal considerations must be put into place for efficient and transparent frameworks for AI.

Reference url

Recent Posts

Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit

By João L. Carapinha

August 19, 2025

A recent G-BA decision provides a systematic evaluation of Glofitamab Gemcitabine DLBCL, combined with Gemcitabine and Oxaliplatin (GemOx), for treating adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplantation. The review...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rare Disease Therapies
Health technology assessment (HTA) plays a crucial role in determining whether new therapies are reimbursed within healthcare systems. At the July 18, 2025 meeting of the Adviescommissie Pakket (ACP), two high-profile orphan drugs—omaveloxolone (Skyclarys®) for Friedreich’s ataxia and exagamgloge...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms

By Staff Writer

August 18, 2025

Eli Lilly has issued a statement advocating for US drug pricing reforms. It emphasizes maintaining America's leadership in biopharmaceutical innovation. The Eli Lilly innovation statement highlights a $50 billion US manufacturing investment since 2020. This includes four new sites and opposes tar...